Stay updated with breaking news from Nasdaq Dmac. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. DiaMedica Therapeutics (NASDAQ:DMAC […]
Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) were up 0.7% during mid-day trading on Thursday . The company traded as high as $3.02 and last traded at $2.91. Approximately 44,769 shares traded hands during trading, a decline of 42% from the average daily volume of 77,022 shares. The stock had previously closed […]
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) shares fell 8.6% on Monday . The company traded as low as $2.50 and last traded at $2.56. 183,312 shares changed hands during trading, an increase of 113% from the average session volume of 85,998 shares. The stock had previously closed at $2.80. Wall Street Analyst Weigh […]
DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Monday, August 14th. Analysts expect the company to announce earnings of ($0.22) per share for the quarter. DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) last announced its quarterly earnings data on Monday, May 15th. The […]
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 796,100 shares, a growth of 11.6% from the June 30th total of 713,600 shares. Approximately 4.5% of the shares of the stock are sold short. Based […]